Clinical Trial Update: Curcumin Biomarkers [Phase 1]

View source ↗

Summary

This clinical trial update indicates a completed Phase 1 study evaluating curcumin biomarkers in colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Curcumin (curcumin)

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Colorectal Cancer | Phase 1 | Status: COMPLETED